Interestingly, CHKA is significantly overexpressed in localized primary and metastatic PCa lesions, where it is an androgen-regulated gene and appears to be an independent predictor of biochemical recurrence-free survival in association with other clinical variables [29]. The gene discussed is CHKA; the disease is posterior cortical atrophy.